medigraphic.com

2017, Number S1

<< Back Next >>

Rev Mex Anest 2017; 40 (S1)

Complications in pulmonary hypertension

Gutiérrez-García A

Language: Spanish
References: 15
Page: 145-149
PDF size: 202.07 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37: 67-119 [Epub 2015 Aug 29]

  2. Farber HW, Loscalzo J. Mechanism of disease: pulmonary arterial hypertension. N Engl J Med. 2004;351:1655-1665.

  3. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barberá JA y cols. Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión pulmonar. Rev Esp Cardiol. 2009;62:1464.e1-e58.

  4. Guazzi M, Borlaug B. Hipertensión pulmonar debida a cardiopatía izquierda. Circulation. 2013;25-41.

  5. Vachiéry JL, Adir Y, Barberá JA, Champion H, Coghlan JG, Cottlín V. et al. Pulmonary hipertension due to left heart diseases. JACC, 2013; 62 (25) Supl. D: 100-108.

  6. Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol. 2013;62:100-108.

  7. Sánchez García M, García Lunar I, Sayago Silva I, Gómez Bueno M, Segovia J. Actualización en hipertensión pulmonar asociada a cardiopatía izquierda: diagnóstico y tratamiento. Av Hipertens Pulmon. 2013;26:1-5.

  8. Lau EM, Humbert M. A critical appraisal of the Updated 2014 Nice pulmonary hypertension classification system. Can J Cardiol. 2015;31:367-374.

  9. Grupo de Trabajo sobre el diagnóstico y tratamiento de la Hipertensión Arterial Pulmonar de la Sociedad Europea de Cardiología. Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la hipertensión arterial pulmonar. Rev Esp Cardiol. 2005;58:523-566.

  10. Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J. 2013;41:217-223.

  11. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35:3452-3462.

  12. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest. 2013;143:758-766.

  13. Bonderman D, Ghio S, Felix SB, Ghofrani HA, Michelakis E, Mitrovic V, et al. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, doseranging hemodynamic study. Circulation. 2013;128:502-511.

  14. Caminati A, Cassandro R, Harari S. Pulmonary hypertension in chronic interstitial lung diseases. Eur Respir Rev. 2013;22:292-301.

  15. Cottin V, Le Pavec J, Prévot G, Mal H, Humbert M, Simonneau G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35:105-111.




2020     |     www.medigraphic.com